These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6500167)

  • 21. Atenolol and chlorthalidone in combination in the management of older hypertensive patients: a randomized clinical trial.
    Backhouse CI; Hosie J; Tweed JA; Edwards KG
    Curr Med Res Opin; 1985; 9(6):378-83. PubMed ID: 3886301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hypertensive therapy. Improvement of compliance with a daily regimen of a two-drug combination].
    Otter HP
    ZFA (Stuttgart); 1982 Mar; 58(9):533-6. PubMed ID: 7080657
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of the effectiveness of a beta blocker (atenolol) and a diuretic (chlorthalidone) in black hypertensive patients.
    Grell GA; Forrester TE; Alleyne GA
    South Med J; 1984 Dec; 77(12):1524-9. PubMed ID: 6390696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of hypertensive hyperuricemic patients with a new beta blocker-diuretic combination].
    Brandstetter G; Hoffmann H
    Wien Klin Wochenschr; 1984 Sep; 96(18):696-9. PubMed ID: 6240831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atenolol, methyldopa, and chlorthalidone in moderate hypertension.
    Webster J; Jeffers TA; Galloway DB; Petrie JC; Barker NP
    Br Med J; 1977 Jan; 1(6053):76-8. PubMed ID: 12850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atenolol and chlorthalidone administered alone and in combination for essential hypertension.
    Boike SC; Durley Y; Cubberley RB
    Clin Pharm; 1982; 1(5):449-53. PubMed ID: 6764166
    [No Abstract]   [Full Text] [Related]  

  • 27. [Value of heart rate recordings in selecting the initial treatment of hypertension].
    Gómez Marino MA; Alonso Rodríguez C; Gayán Laviña R; Jiménez Ramos A
    Rev Clin Esp; 1989 Mar; 184(4):168-73. PubMed ID: 2740542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic treatment with tibalosine in essential hypertension.
    Staessen J; Fagard R; Fiocchi R; Lijnen P; M'Buyamba-Kabangu JR; Amery A
    Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):162-76. PubMed ID: 3516092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled clinical trial of cadralazine as a second-step drug in the treatment of hypertension.
    Catalano M; Parini J; Romano M; Libretti A
    Eur J Clin Pharmacol; 1985; 28(2):135-8. PubMed ID: 3886402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prolonged cardioselective blockade of beta-1 adrenoreceptors in combination with increased diuresis as a method of choice in the treatment of hypertension].
    Ivashkin VT; Grigor'ev IuV; Sinopal'nikov AI; Korneev NV; Levitskiĭ DN; KazakovaIG ; Virs EA
    Kardiologiia; 1991 Aug; 31(8):59-61. PubMed ID: 1795477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Atenolol-chlorthalidone combination vs placebo: controlled clinical trial in patients with medium-mild arterial hypertension].
    Campana C; Ferrario M; Tondi C; Montemartini C
    Minerva Cardioangiol; 1985 Oct; 33(10):643-7. PubMed ID: 3908972
    [No Abstract]   [Full Text] [Related]  

  • 32. The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life.
    Wassertheil-Smoller S; Oberman A; Blaufox MD; Davis B; Langford H
    Am J Hypertens; 1992 Jan; 5(1):37-44. PubMed ID: 1736933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The clinical profile of hypertensive patients can predict the need for combining a second or third drug with atenolol in the initial treatment of light and moderate essential arterial hypertension].
    Coca A; de la Sierra A; Sobrino J; Aguilera MT; Lluch MM; Sánchez M; Picado MJ; Urbano-Márquez A
    Med Clin (Barc); 1990 Sep; 95(9):329-32. PubMed ID: 2280617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term therapy with atenolol and chlorthalidone in medium- and high-grade arterial hypertension].
    Budriesi N; Adalio G; Zamboni A; Turina MC
    G Clin Med; 1986 Apr; 67(2):109-13. PubMed ID: 3792715
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical effectiveness of low-dose chlorthalidone (6.25 mg) + atenolol combination in stage I hypertensive patients: a multicenter, randomized, controlled study.
    Pareek A; Karnik N; Salagre SB; Zawar SD; Joglekar VK; Chandurkar N; Naik GS
    Curr Med Res Opin; 2008 Jun; 24(6):1771-9. PubMed ID: 18479589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Normalization of ventricular compliance and hypertrophy in arterial hypertension. Double-blind study with 2 combinations of a beta blocker and diuretic].
    Mohallen KL; do Patrocínio LL; Célnik D; Kruczan DD; Pinheiro L; Weitzel LH; Bosco J; Sekeff JA; Azevedo Ade C
    Arq Bras Cardiol; 1987 Jun; 48(6):345-50. PubMed ID: 2965568
    [No Abstract]   [Full Text] [Related]  

  • 37. Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects.
    Feher MD; Henderson AD; Wadsworth J; Poulter C; Gelding S; Richmond W; Sever PS; Elkeles RS
    J Hum Hypertens; 1990 Oct; 4(5):571-7. PubMed ID: 1980930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group.
    Kostis JB; Davis BR; Cutler J; Grimm RH; Berge KG; Cohen JD; Lacy CR; Perry HM; Blaufox MD; Wassertheil-Smoller S; Black HR; Schron E; Berkson DM; Curb JD; Smith WM; McDonald R; Applegate WB
    JAMA; 1997 Jul; 278(3):212-6. PubMed ID: 9218667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
    Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interference on metabolism induced by muzolimine and chlorthalidone in type II hypertensive diabetics.
    Pagano G; Dal Molin V; Bozzo C; Carta Q
    Z Kardiol; 1985; 74 Suppl 2():80-3. PubMed ID: 3890395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.